PIA
CVS icon

Piedmont Investment Advisors’s CVS Health CVS Stock Holding History

Piedmont Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-133,719
Closed -$7.93M – 164
2020
Q1 		$7.93M Buy
133,719
+4,383
+3% +$293K 0.31% 72
2019
Q4 		$9.61M Buy
129,336
+2,754
+2% +$193K 0.33% 74
2019
Q3 		$7.98M Buy
126,582
+7,465
+6% +$442K 0.31% 83
2019
Q2 		$6.49M Sell
119,117
-8,974
-7% -$483K 0.26% 99
2019
Q1 		$6.91M Buy
128,091
+2,458
+2% +$152K 0.28% 88
2018
Q4 		$8.23M Sell
125,633
-27,336
-18% -$2.04M 0.39% 58
2018
Q3 		$12M Buy
152,969
+4,115
+3% +$294K 0.51% 38
2018
Q2 		$9.58M Sell
148,854
-24,891
-14% -$1.64M 0.46% 49
2018
Q1 		$10.8M Sell
173,745
-111,431
-39% -$8M 0.29% 90
2017
Q4 		$20.7M Buy
285,176
+285
+0.1% +$20.7K 0.42% 56
2017
Q3 		$23.2M Sell
284,891
-10,266
-3% -$812K 0.49% 53
2017
Q2 		$23.7M Sell
295,157
-7,351
-2% -$580K 0.53% 44
2017
Q1 		$23.7M Buy
302,508
+45,925
+18% +$3.67M 0.49% 56
2016
Q4 		$20.2M Buy
256,583
+6,871
+3% +$556K 0.42% 69
2016
Q3 		$22.2M Sell
249,712
-22,848
-8% -$2.16M 0.48% 60
2016
Q2 		$26.1M Sell
272,560
-338,843
-55% -$33.8M 0.54% 54
2016
Q1 		$63.4M Buy
611,403
+3,395
+0.6% +$330K 1.33% 14
2015
Q4 		$59.4M Buy
608,008
+24,083
+4% +$2.36M 1.25% 17
2015
Q3 		$56.3M Sell
583,925
-50,787
-8% -$5.34M 1.27% 16
2015
Q2 		$66.6M Buy
634,712
+177,342
+39% +$18.1M 1.41% 12
2015
Q1 		$47.2M Sell
457,370
-24,906
-5% -$2.52M 2.89% 3
2014
Q4 		$46.4M Sell
482,276
-218,039
-31% -$19.2M 2.81% 3
2014
Q3 		$55.7M Buy
700,315
+179,992
+35% +$14.2M 2.89% 5
2014
Q2 		$39.2M Sell
520,323
-122,858
-19% -$9.29M 2.05% 17
2014
Q1 		$48.1M Sell
643,181
-62,227
-9% -$4.4M 2.64% 6
2013
Q4 		$50.5M Sell
705,408
-244,374
-26% -$15.7M 2.71% 6
2013
Q3 		$53.9M Sell
949,782
-170,045
-15% -$10.1M 2.82% 5
2013
Q2 		$64M Buy
+1,119,827
New +$64.9M 2.87% 2

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Piedmont Investment Advisors's CVS Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of CVS Health (CVS) in Q2 2020, closing a stake of 133,719 shares — an estimated $7.93M sold.

Piedmont Investment Advisors first reported a position in CVS in Q2 2013 and held it in 28 quarters. The position peaked at $66.6M in Q2 2015. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 133,719 CVS Health shares in Q2 2020, an estimated $7.93M.
  • Piedmont Investment Advisors first reported a position in CVS Health in Q2 2013 and held it in 28 quarters.
  • Piedmont Investment Advisors's CVS Health position peaked at $66.6M in Q2 2015.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.